(Q43698881)

26 November 2017

title

Fiscal consequences of changes in morbidity and mortality attributed to rotavirus immunisation (English)

1 reference

26 November 2017

3

Maarten J Postma

1 reference

26 November 2017

Nikolaos Kotsopoulos

1

1 reference

26 November 2017

Mark P Connolly

series ordinal

2

1 reference

26 November 2017

Raymond C W Hutubessy

series ordinal

4

1 reference

26 November 2017

language of work or name

English

0 references

publication date

18 September 2013

1 reference

26 November 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

26 November 2017

volume

31

1 reference

26 November 2017

issue

46

1 reference

26 November 2017

page(s)

5430-5434

1 reference

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.002

Determinants of Long-Term Growth: A Bayesian Averaging of Classical Estimates (BACE) Approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.002

Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.002

Global Illness and Deaths Caused by Rotavirus Disease in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.002

The impact of rotavirus vaccination on discounted net tax revenue in Egypt: a government perspective analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.002

Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.002

Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.002

New Estimates for the Shadow Economies all over the World

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.002

WHO Guide for standardisation of economic evaluations of immunization programmes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.002

Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.002

10.1016/J.VACCINE.2013.09.002

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference